Oak Hill Bio to Participate in 2022 Wells Fargo Private Biotech Symposium
businesswire.com
news
2022-05-27 00:00:00

May 27, 2022 08:00 AM Eastern Daylight Time OXFORDSHIRE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oak Hill Bio ('Oak Hill'), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, today announced that members of its senior leadership team will participate in virtual one-on-one meetings with investors at the upcoming 2022 Wells Fargo Private Biotech Symposium taking place on June 1, 2022.
